TPG-backed Adare Pharmaceuticals buys Orbis Biosciences

Adare Pharmaceuticals Inc, which is backed by TPG Capital, has acquired Lenexa, Kansas-based Orbis Biosciences, a pharmaceutical manufacturing technology company.

5 May 2020•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles